Singapore Lumasiran Market (2025-2031) | Outlook, Value, Companies, Segmentation, Size & Revenue, Growth, Analysis, Forecast, Competitive Landscape, Industry, Share, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Singapore Country Macro Economic Indicators

3.2 Singapore Lumasiran Market Revenues & Volume, 2021 & 2031F

3.3 Singapore Lumasiran Market - Industry Life Cycle

3.4 Singapore Lumasiran Market - Porter's Five Forces

3.5 Singapore Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Singapore Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Singapore Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F

3.8 Singapore Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.9 Singapore Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.10 Singapore Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases in Singapore, such as primary hyperoxaluria type 1 (PH1), which lumasiran is indicated for.

4.2.2 Growing awareness and adoption of advanced therapies for genetic disorders in the healthcare sector.

4.2.3 Supportive government initiatives and policies promoting the development and adoption of innovative treatments like lumasiran.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for new pharmaceutical products in Singapore.

4.3.2 High cost associated with lumasiran treatment, limiting accessibility for some patients.

4.3.3 Competition from existing therapies or alternative treatment options for rare genetic disorders.

6.1 Singapore Lumasiran Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Singapore Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Singapore Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F

6.1.4 Singapore Lumasiran Market Revenues & Volume, By others, 2021- 2031F

6.2 Singapore Lumasiran Market, By Application

6.2.1 Overview and Analysis

6.2.2 Singapore Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F

6.2.3 Singapore Lumasiran Market Revenues & Volume, By Others, 2021- 2031F

6.3 Singapore Lumasiran Market, By Dosage form

6.3.1 Overview and Analysis

6.3.2 Singapore Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F

6.3.3 Singapore Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F

6.4 Singapore Lumasiran Market, By Route of Administration

6.4.1 Overview and Analysis

6.4.2 Singapore Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.4.3 Singapore Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F

6.4.4 Singapore Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F

6.4.5 Singapore Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F

6.5 Singapore Lumasiran Market, By End-Users

6.5.1 Overview and Analysis

6.5.2 Singapore Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F

6.5.3 Singapore Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.4 Singapore Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F

6.6 Singapore Lumasiran Market, By Distribution Channel

6.6.1 Overview and Analysis

6.6.2 Singapore Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.6.3 Singapore Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.6.4 Singapore Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7.1 Singapore Lumasiran Market Export to Major Countries

7.2 Singapore Lumasiran Market Imports from Major Countries

8.1 Patient enrollment in clinical trials for lumasiran in Singapore.

8.2 Number of healthcare providers trained in prescribing and administering lumasiran.

8.3 Rate of adverse events reported related to lumasiran treatment in Singapore.

8.4 Patient adherence and compliance rates with lumasiran therapy.

8.5 Level of patient satisfaction and improvement in quality of life post-lumasiran treatment.

9.1 Singapore Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Singapore Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Singapore Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F

9.4 Singapore Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.5 Singapore Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.6 Singapore Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Singapore Lumasiran Market Revenue Share, By Companies, 2024

10.2 Singapore Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters